Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

28%

5 of 18 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (15)
P 2 (1)

Trial Status

Completed18
Unknown2
Not Yet Recruiting1
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT07216846Not ApplicableRecruiting

The Geriatric Emergency Department Pharmacologic Harm Prevention Project

NCT06723860Not Yet Recruiting

The Critical Care Recovery Program: Use of a Structured Clinic Visit to Reduce Adverse Drug Events in ICU Survivors

NCT01091038Phase 2CompletedPrimary

Improving Safety by Basic Computerizing Outpatient Prescribing

NCT04479553Unknown

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

NCT04692220CompletedPrimary

Drug-Related Problems : Focus on Age and Diabetes

NCT02482025Not ApplicableCompleted

The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial

NCT02059044Not ApplicableCompletedPrimary

Information Systems-enabled Outreach Program for Adverse Drug Events

NCT02378220Not ApplicableCompletedPrimary

Pharmacogenetic Testing Among Home Health Patients

NCT01179867Not ApplicableCompleted

Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge

NCT02593916CompletedPrimary

Response to Medication Registry

NCT02239237Completed

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

NCT02026453Not ApplicableCompletedPrimary

Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy

NCT01764204CompletedPrimary

Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years

NCT02191358CompletedPrimary

YouScript IMPACT Registry

NCT02805270Not ApplicableCompletedPrimary

Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization

NCT01531088Not ApplicableCompletedPrimary

Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes

NCT00780572Not ApplicableCompletedPrimary

Implementation of Real-time ADE Surveillance and Decision Support

NCT01337063Not ApplicableCompletedPrimary

Multi-Center Medication Reconciliation Quality Improvement Study

NCT00013143Not ApplicableCompletedPrimary

Patient Profiling and Provider Feedback to Reduce Adverse Drug Events

NCT00606606Not ApplicableWithdrawnPrimary

Reducing Adverse Drug Events in the Nursing Home

Scroll to load more

Research Network

Activity Timeline